Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17.3M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
+13.2M
-
Total reported value, excl. options
-
$79.1M
-
Value change
-
+$78.4M
-
Number of buys
-
116
-
Price
-
$5.92
Significant Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q4 2023
120 filings reported holding MURA - Mural Oncology plc - Ordinary shares, nominal value $0.01 per share as of Q4 2023.
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
of 17.3M outstanding shares and own 77.4% of the company stock.
Largest 10 shareholders include WESTFIELD CAPITAL MANAGEMENT CO LP (1.99M shares), ARMISTICE CAPITAL, LLC (1.66M shares), VANGUARD GROUP INC (1.52M shares), BlackRock Inc. (1.17M shares), Alta Fundamental Advisers LLC (600K shares), Newtyn Management, LLC (445K shares), Prosight Management, LP (419K shares), Bank of New York Mellon Corp (399K shares), STATE STREET CORP (378K shares), and GEODE CAPITAL MANAGEMENT, LLC (356K shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.